The protective effect of biologic and targeted-synthetic therapies on developing multisystem inflammatory syndrome in children
BackgroundMultisystem Inflammatory Syndrome in Children (MIS-C) is a severe, life threatening, complication that arises weeks after acute Coronavirus disease 2019 (COVID-19) infection, often presenting with fever and diverse systemic symptoms. Limited data exists on the effectiveness of biologic and...
Saved in:
Main Authors: | Lana Khoury, Adi Miller-Barmak, Shereen Shehadeh, Hilla Cohen, Dana Hadar, Mohamad Hamad Saied |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2025.1607637/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Associated with COVID-19 Infection Related Multisystem Inflammatory Syndrome in Children: A Multicenter Matched Case-Control Study
by: Buddhaporn Prasertsakul, et al.
Published: (2025-05-01) -
Prognostic Value of Caspase-3 and Cardiac Troponin I in Assessing Cardiovascular Risk in Pediatric COVID-19 and Multisystem Inflammatory Syndrome
by: Kozak K, et al.
Published: (2025-05-01) -
Clinical Characteristics and Outcomes in Multisystemic Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A 12-Month Prospective Study
by: Viorela Gabriela Nitescu, et al.
Published: (2025-06-01) -
Uveitis in spondyloarthritis: current possibilities of anti-inflammatory therapy
by: A. A. Godzenko, et al.
Published: (2025-05-01) -
Synthetic fuels
by: Probstein, Ronald F.
Published: (1982)